Anemia Clinical Trial
Official title:
Building Capacity for Sustainable Livelihoods and Health Through Public-private Linkages in Agriculture and Health Systems
NCT number | NCT01985243 |
Other study ID # | S065653 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 2013 |
Est. completion date | August 5, 2018 |
Verified date | August 2018 |
Source | McGill University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Despite recent economic growth in Ghana, the prevalence of childhood malnutrition remains
high. Wasting prevalence affected 29% among 6- to 8-months-old infants in 2008. Poor
nutrition contributes to about one-third of child mortality, diminishes cognitive
development, and is a major determinant of maternal mortality. The specific objectives of the
5-year project are to: (1) enhance human capacity of government, civil, and private
institutions through improvement of knowledge and skills of personnel in agriculture,
nutrition and health, entrepreneurship, and pedagogy; (2) identify information needs of local
institutions that are not presently met and develop a representative and sustainable
longitudinal data system to support evidence-based decision-making in programs; (3) increase
vulnerable households' access to quality services in agriculture/fisheries, nutrition and
health, and finance; (4) implement integrated intervention activities to improve infant and
young child and adolescent nutrition outcomes; and (5) examine differential benefits of the
interventions for diverse vulnerable populations. The project comprises two major activities:
part I - the creation of a longitudinal data system to support evidence-based decision-making
in programs, and part II - the implementation of intervention activities to improve nutrition
outcomes.
The survey will include demographic, socioeconomic, health, diet, and nutritional status
information collected annually from a representative same of 1500 households with infants
(0-12 mo) and 1500 households with adolescents (9-12 y). The data will be analyzed and
presented rapidly each year to district program and policy leaders to assist them in
developing their activity plans for the following year.
Status | Completed |
Enrollment | 3390 |
Est. completion date | August 5, 2018 |
Est. primary completion date | March 31, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A to 15 Years |
Eligibility |
Inclusion Criteria: - household with infant < 12 mo or adolescent 10-15 y - Living in selected communities of Upper Manya Krobo District (Ghana) Exclusion Criteria: - infant or adolescent has medical condition that limits dietary intakes or growth |
Country | Name | City | State |
---|---|---|---|
Canada | McGill University | Montreal | Quebec |
Canada | World Vision | Toronto | Ontario |
Ghana | University of Ghana | Legon |
Lead Sponsor | Collaborator |
---|---|
McGill University | Foreign Affairs, Trade and Development, Canada, World Vision |
Canada, Ghana,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Women's income | Income-generation of child bearing-aged women will be assessed at enrollment and every 12 months for 5 years | at enrollment and every 12 months for 5 years | |
Primary | Dietary diversity | Dietary diversity of infants and young children, based on the World Health Organization's 7 food group list. This will be assessed at enrollment (which 0-11.9 mo of age) and then every 12 months for 5 years. | At enrollment and every 12 months for 5 years | |
Primary | Anemia prevalence | Anemia prevalence in adolescent girls will be assessed at enrollment and every 12 months for 4 years | at enrollment and every 12 months for 4 years | |
Secondary | Wasting prevalence | Weight-for-height of infants and young children will be assessed at at enrollment and every 12 months for 5 years | at enrollment and every 12 months for 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Completed |
NCT01432717 -
Study of ACE-536 in Healthy Postmenopausal Women
|
Phase 1 | |
Completed |
NCT01458028 -
Age and Gender Effects on the Pharmacokinetics of BAY85-3934
|
Phase 1 |